Minocycline modulates cytokine and gene expression profiles in the brain after whole-body exposure to radiation

In Vivo

Volumn 28, Issue 1, 2014, Pages 21-32

  Mehrotra, Shalini ^a   Pecaut, Michael J ^a   Gridley, Daila S ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Gamma radiation; Inflammation; Mouse model; Radioprotectant

Indexed keywords

BETA CATENIN; INTERLEUKIN 10; INTERLEUKIN 15; MINOCYCLINE; NITRIC OXIDE SYNTHASE; VASCULOTROPIN; NEUROPROTECTIVE AGENT; RADIOPROTECTIVE AGENT; TRANSCRIPTOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ARTICLE; BRAIN RADIATION; FEMALE; GENE EXPRESSION PROFILING; IMMUNOMODULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION EXPOSURE; TRANSCRIPTION REGULATION; UPREGULATION; WHOLE BODY RADIATION; ANIMAL; APOPTOSIS; BIOSYNTHESIS; BRAIN; DRUG EFFECT; GAMMA RADIATION; GENE EXPRESSION REGULATION; INFLAMMATION; MOUSE MODEL; RADIOPROTECTANT;

APOPTOSIS; GAMMA RADIATION; INFLAMMATION; MOUSE MODEL; RADIOPROTECTANT;

ANIMALS; BRAIN; GAMMA RAYS; GENE EXPRESSION REGULATION; INTERLEUKIN-10; INTERLEUKIN-15; MICE; MINOCYCLINE; NEUROPROTECTIVE AGENTS; RADIATION DOSAGE; RADIATION-PROTECTIVE AGENTS; TRANSCRIPTOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WHOLE-BODY IRRADIATION;

EID: 84906926249     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Simonsen LC, Cucinotta FA, Atwell W and Nealy JE: Temporal analysis of the October 1989 proton flare using computerized anatomical models. Radiat Res 133: 1-11, 1993.
2. Singh VK, Ducey EJ, Brown DS and Whitnall MH: A review of work ongoing at Armed Forces Radiobiology Research Institute. Int J Radiat Biol 88: 296-310, 2001.
3. Dainiak N, Waselenko JK, Armitage JO, MacVittie TJ and Farese AM: The hematologist and radiation casualties. Hematology Am Soc Hematol Educ Program 2003: 473-496, 2003.
4. Moore AH, Olschowka JA, Williams JP, Paige SL and O'Banion MK: Radiation-induced edema is dependent on cyclooxygenase 2 activity in mouse brain. Radiat Res 161: 153-160, 2004.
5. Moravan MJ, Olschowka JA, Williams JP and O'Banion MK: Cranial irradiation leads to acute and persistent neuroinflammation with delayed increases in T-cell infiltration and CD11c expression in C57BL/6 mouse brain. Radiat Res 176: 459-473, 2011.
6. Hong JH, Chiang CS, Campbell IL, Sun JR, Withers HR and McBride WH: Induction of acute phase gene expression by brain irradiation. Int J Radiat Oncol Biol Phys 33: 619-626, 1995.
7. Raju U, Gumin GJ and Tofilon PJ: NF kappa B activity and target gene expression in the rat brain after one and two exposures to ionizing radiation. Radiat Oncol Investig 7: 145-152, 1999.
8. Raju U, Gumin GJ and Tofilon PJ: Radiation-induced transcription factor activation in the rat cerebral cortex. Int J Radiat Biol 76: 1045-1053, 2000.
9. Ramanan S, Zhao W, Riddle DR and Robbins ME: Role of PPARs in radiation-induced brain injury. PPAR Res 2010: Article ID 234975, 2010.
10. Rola R, Fishman K, Baure J, Rosi S, Lamborn KR, Obenaus A, Nelson GA and Fike JR: Hippocampal neurogenesis and neuroinflammation after cranial irradiation with (56)Fe particles. Radiat Res 169: 626-632, 2008.
11. Bálentová S, Hajtmanová E, Mellová Y, Bošelová L, Fuseková E, Adamkov EOM, Ochodnická E and Adamkov M: Alterations in the rat forebrain apoptosis following exposure to ionizing radiation. Biologia 66: 701-705, 2011.
12. Reh TA: Neural stem cells: form and function. Nat Neurosci 5: 392-394, 2002.
13. van Praag H, Christie BR, Sejnowski TJ and Gage FH: Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc Natl Acad Sci USA 96: 13427-13431, 1999.
14. Kempermann G, Kuhn HG and Gage FH: More hippocampal neurons in adult mice living in an enriched environment. Nature 386: 493-495, 1997.
15. Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC and Mitchell JB: Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist 15: 360-371, 2010.
16. Kos I, Reboucas JS, DeFreitas-Silva G, Salvemini D, Vujaskovic Z, Dewhirst MW, Spasojevic I and Batinic-Haberle I: Lipophilicity of potent porphyrin-based antioxidants: comparison of ortho and meta isomers of mn(iii) n-alkylpyridylporphyrins. Free Radic Biol Med 47: 72-78, 2009.
17. Zhang H, Zhai Z, Wang Y, Zhang J, Wu H, Li C, Li D, Lu L, Wang X, Chang J, Hou Q, Ju Z, Zhou D and Meng A: Resveratrol ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice. Free Radic Biol Med 54: 40-50, 2013.
18. Shirazi A, Ghobadi G and Ghazi-Khansari M: A radiobiological review on melatonin: a novel radioprotector. J Radiat Res 48: 263-272, 2007.
19. Kim HS and Suh YH: Minocycline and neurodegenerative diseases. Behav Brain Res 196: 168-179, 2009.
20. Dean OM, Data-Franco J, Giorlando F and Berk M: Minocycline: therapeutic potential in psychiatry. CNS Drugs 26: 391-401, 2012.
21. Chaudhry IB, Hallak J, Husain N, Minhas F, Stirling J, Richardson P, Dursun S, Dunn G and Deakin B: Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment. J Psychopharmacol 26: 1185-1193, 2012.
22. Levkovitz Y, Mendlovich S, Riwkes S, Braw Y, Levkovitch-Verbin H, Gal G, Fennig S, Treves I and Kron S: A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. J Clin Psychiatry 71: 138-149, 2010.
23. Markovic DS, Vinnakota K, van Rooijen N, Kiwit J, Synowitz M, Glass R and Kettenmann H: Minocycline reduces glioma expansion and invasion by attenuating microglial MT1-MMP expression. Brain Behav Immun 25: 624-628, 2011.
24. Kraus RL, Pasieczny R, Lariosa-Willingham K, Turner MS, Jiang A and Trauger JW: Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity. J Neurochem 94: 819-827, 2005.
25. Tikka T, Usenius T, Tenhunen M, Keinanen R and Koistinaho J: Tetracycline derivatives and ceftriaxone, a cephalosporin antibiotic, protect neurons against apoptosis induced by ionizing radiation. J Neurochem 78: 1409-1414, 2001.
26. Mehrotra S, Pecaut MJ and Gridley DS: Analysis of minocycline as a countermeasure against acute radiation syndrome. In Vivo 26: 743-758, 2012.
27. Mehrotra S, Pecaut MJ and Gridley DS: Effects of minocycline on hematopoietic recovery after whole-body irradiation. In Vivo 27: 11-28, 2013.
28. Gridley DS, Pecaut MJ, Rizvi A, Coutrakon GB, Luo-Owen X, Makinde AY and Slater JM: Low-dose, low-dose-rate proton radiation modulates CD4(+) T cell gene expression. Int J Radiat Biol 85: 250-261, 2009.
29. Lee SM, Yune TY, Kim SJ, Park DW, Lee YK, Kim YC, Oh YJ, Markelonis GJ and Oh TH: Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat. J Neurotrauma 20: 1017-1027, 2003.
30. Shi P, Diez-Freire C, Jun JY, Qi Y, Katovich MJ, Li Q, Sriramula S, Francis J, Sumners C and Raizada MK: Brain microglial cytokines in neurogenic hypertension. Hypertension 56: 297-303, 2010.
31. Ng TH, Britton GJ, Hill EV, Verhagen J, Burton BR and Wraith DC: Regulation of adaptive immunity: the role of interleukin-10. Front Immunol 4: Article 129, 2013.
32. + T cell activation during HIV infection. Nature Medicine 16: 452-459, 2010.
33. Asadullah K, Sterry W and Volk HD: Interleukin-10 therapy - review of a new approach. Pharmacol Rev 55: 241-269, 2003.
34. Bachis A, Colangelo AM, Vicini S, Doe PP, De Bernardi MA, Brooker G and Mocchetti I: Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J Neurosci 21: 3104-3112, 2001.
35. Brewer KL, Bethea JR and Yezierski RP: Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury. Exp Neurol 159: 484-493, 1999.
36. Kim YS, Jo DH, Lee H, Kim JH, Kim KW and Kim JH: Nerve growth factor-mediated vascular endothelial growth factor expression of astrocyte in retinal vascular development. Biochem Biophys Res Commun 431: 740-745, 2013.
37. Harmey JH, Dimitriadis E, Kay E, Redmond HP and Bouchier-Hayes D: Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1. Ann Surg Oncol 5: 271-278, 1998.
38. Hitchon C, Wong K, Ma G, Reed J, Lyttle D and El-Gabalawy H: Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis Rheum 46: 2587-2597, 2002.
39. Sakata H, Niizuma K, Yoshioka H, Kim GS, Jung JE, Katsu M, Narasimhan P, Maier CM, Nishiyama Y and Chan PH: Minocyclinepreconditioned neural stem cells enhance neuroprotection after ischemic stroke in rats. J Neurosci 32: 3462-3473, 2012.
40. Hollborn M, Wiedemann P, Bringmann A and Kohen L: Chemotactic and cytotoxic effects of minocycline on human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 51: 2721-2729, 2010.
41. Warner-Schmidt JL, Madsen TM and Duman RS: Electroconvulsive seizure restores neurogenesis and hippocampus-dependent fear memory after disruption by irradiation. Eur J Neurosci 27: 1485-1493, 2008.
42. Kernt M, Neubauer AS, Eibl KH, Wolf A, Ulbig MW, Kampik A and Hirneiss C: Minocycline is cytoprotective in human trabecular meshwork cells and optic nerve head astrocytes by increasing expression of XIAP, survivin, and Bcl-2. Clin Ophthalmol 4: 591-604, 2010.
43. Barreto G, White RE, Ouyang Y, Xu L and Giffard RG: Astrocytes: targets for neuroprotection in stroke. Cent Nerv Syst Agents Med Chem 11: 164-173, 2011.
44. Rossol M, Heine H, Meusch U, Quandt D, Klein C, Sweet MJ and Hauschildt S: LPS-induced cytokine production in human monocytes and macrophages. Crit Rev Immunol 31: 379-446, 2011.
45. Pan W, Wu X, He Y, Hsuchou H, Huang EY, Mishra PK and Kastin AJ: Brain interleukin-15 in neuroinflammation and behavior. Neurosci Biobehav Rev 37: 184-192, 2013.
46. Pan W, Wu X, Kastin AJ, Zhang Y, Hsuchou H, Halberg F, Chatu F, Khan RS, Robert B and Cornelissen-Guillaume GG: Potential protective role of IL15Rα during inflammation. J Mol Neurosci 43: 412-423, 2011.
47. Gomez-Nicola D, Valle-Argos B, Pallas-Bazarra N and Nieto-Sampedro M: Interleukin-15 regulates proliferation and self-renewal of adult neural stem cells. Mol Bio Cell 22: 1960-1970, 2011.
48. Müller M, Carter S, Hofer MJ and Campbell IL: Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity - a tale of conflict and conundrum. Neuropathol Appl Neurobiol 36: 368-387, 2010.
49. Gattass CR, King LB, Luster AD and Ashwell JD: Constitutive expression of IP-10 in lymphoid organs and inducible expression in T cells and thymocytes. J Exp Med 179: 1373-1378, 1994.
50. Nawaz MI, Van Raemdonck K, Mohammad G, Kangave D, Van Damme J, Abu El-Asrar AM and Struyf S: Autocrine CCL2, CXCL4, CXCL9 and CXCL10 signal in retinal endothelial cells and are enhanced in diabetic retinopathy. Exp Eye Res 109: 67-76, 2013.
51. Lödermann B, Wunderlich R, Frey S, Schorn C, Stangl S, Rödel F, Keilholz L, Fietkau R, Gaipl US and Frey B: Low dose ionizing radiation leads to a NF-kB dependent decrease secretion of active IL-1β by activated macrophages with a discontinuous dose-dependency. Int J Radiat Biol 88: 727-734, 2012.
52. Schaue D, Kachikwu EL and McBride WH: Cytokines in radiobiological responses: a review. Radiat Res 178: 505-523, 2012.
53. Choi Y, Kim HS, Shin KY, Kim EM, Kim M, Park CH, Jeong YH, Yoo J, Lee JP, Chang KA, Kim S and Suh YH: Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models. Neuropsychopharmacology 32: 2393-2404, 2007.
54. Tikka T, Fiebich BL, Goldsteins G, Keinanen R and Koistinaho J: Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21: 2580-2588, 2001.
55. Lucas SM, Rothwell NJ and Gibson RM: The role of inflammation in cns injury and disease. Br J Pharmacol 147(Suppl 1): S232-S240, 2006.
56. Rothwell NJ: Annual review prize lecture: cytokines - killers in the brain? J Physiol 514(Pt 1): 3-17, 1999.
57. Pott Godoy MC, Tarelli R, Ferrari CC, Sarchi MI and Pitossi FJ: Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain 131: 1880-1894, 2008.
58. Griffin WS: Inflammation and neurodegenerative diseases. Am J Clin Nutr 83: 470S-474S, 2006.
59. Fike JR, Rosi S and Limoli CL: Neural precursor cells and central nervous system radiation sensitivity. Semin Radiat Oncol 19: 122-132, 2009.
60. Kielian T, Esen N, Liu S, Phulwani NK, Syed MM, Phillips N, Nishina K, Cheung AL, Schwartzman JD and Ruhe JJ: Minocycline modulates neuroinflammation independently of its antimicrobial activity in staphylococcus aureus-induced brain abscess. Am J Pathol 171: 1199-1214, 2007.
61. Ransohoff RM and Brown MA: Innate immunity in the central nervous system. J Clin Invest 122: 1164-171, 2012
62. Mantovani A, Cassatella MA, Costantini C and Jaillon S: Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 11: 519-531, 2011.
63. Erickson MA, Dohi K and Banks WA: Neuroinflammation: a common pathway in CNS diseases as mediated at the bloodbrain barrier. Neuroimmunomodulation 19: 121-130, 2012.
64. Bálentová S, Haltmanová E, Kinclová I, Lehotský J, Dobrota D and Adamkov M: Long-term alterations of cell population in the adult rat forebrain following the exposure to fractionated doses of ionizing radiation. Gen Physiol Biophys 32: 91-100, 2013.
65. Park MK, Kim S, Jung U, Kim I, Kim JK and Roh C: Effect of acute and fractionated irradiation on hippocampal neurogenesis. Molecules 17: 9462-9468, 2012.
66. Sullivan AM, Opacka-Juffry J, Pohl J and Blunt SB: Neuroprotective effects of growth/differentiation factor 5 depend on the site of administration. Brain Res 818: 176-179, 1999.
67. Tansey MG and Szymkowski DE: The TNF superfamily in 2009: new pathways, new indications, and new drugs. Drug Discov Today 14: 1082-1088, 2009.
68. Park CH, Shin TK, Lee HY, Kim SJ and Lee WS: Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice. Korean J Physiol Pharmacol 15: 115-122, 2011.
69. Brederlau A, Faigle R, Kaplan P, Odin P and Funa K: Bone morphogenetic proteins but not growth differentiation factors induce dopaminergic differentiation in mesencephalic precursors. Mol Cell Neurosci 21: 367-378, 2002.
70. Ajami B, Bennett JL, Krieger C, Tetzlaff W and Rossi FM: Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci 10: 1538-1543, 2007.
71. Sagar D, Lamontagne A, Foss CA, Khan ZK, Pomper MG and Jain P: Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood-brain barrier through paracellular transmigration and ERK activation. J Neuroinflammation 9: Article 245, 2012.
72. Hendriks JJ, Teunissen CE, de Vries HE and Dijkstra CD: Macrophages and neurodegeneration. Brain Res Brain Res Rev 48: 185-195, 2005.
73. Sadowski T and Steinmeyer J: Minocycline inhibits the production of inducible nitric oxide synthase in articular chondrocytes. J Rheumatol 28: 336-340, 2001.
74. Lee SM, Yune TY, Kim SJ, Kim YC, Oh YJ, Markelonis GJ and Oh TH: Minocycline inhibits apoptotic cell death via attenuation of TNF-alpha expression following INOS/NO induction by lipopolysaccharide in neuron/glia co-cultures. J Neurochem 91: 568-578, 2004.
75. Macdonald BT, Tamai K and He X: Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9-26, 2009.
76. Wei LC, Ding YX, Liu YH, Duan L, Bai Y, Shi M and Chen LW: Low-dose radiation stimulates Wnt/β-catenin signaling, neural stem cell proliferation and neurogenesis of the mouse hippocampus in vitro and in vivo. Curr Alzheimer Res 9: 278-289, 2012.
77. Soussi T and Lozano G: p53 mutation heterogeneity in cancer. Biochem Biophys Res Commun 331: 834-842, 2005.
78. Sengupta S and Harris CC: p53: traffic cop at the crossroads of DNA repair and recombination. Nat Rev Mol Cell Biol 6: 44-55, 2005.
79. Chuang YT, Lin YC, Lin KH, Chou TF, Kuo WC, Yang KT, Wu PR, Chen RH, Kimchi A and Lai MZ: Tumor suppressor death-associated protein kinase is required for full IL-1β production. Blood 117: 960-970, 2011.
80. Chasseraud M, Liabeuf S, Mozar A, Mentayerri R, Brazier M, Massy ZA and Kamel S: Tumor necrosis factor-related apoptosis-inducing ligand and vascular calcification. Ther Apher Dial 15: 140-146, 2011.